Seeking Alpha

Mike Havrilla » Articles » AMGN |

  • October FDA Calendar Stocks: Tricks or Treats?
    on Oct 16, 2009 • AMGN, BPAX, GSK    
  • FDA Calendar Updates: Acorda, Amgen
    on Aug 04, 2009 • ACOR, AMGN, BIIB    
  • Amgen 2Q Earnings Beat; Raises Guidance, Announces Denosumab Deal
    on Jul 28, 2009 • AMGN    
  • FDA Calendar: 2H09 Binary Event Trades
    on Jul 27, 2009 • ACAD, AEZS, ALKS    
  • FDA Calendar Updates: Amgen, Bayer, Biogen, Noveko, Peplin, Transdel
    on Jul 09, 2009 • AMGN, BAYRY.PK, BIIB    
  • FDA Calendar Updates: Amgen, Amicus, Oncothyreon and Medarex
    on Jun 23, 2009 • AMGN, BMY, EURX    
  • FDA, Clinical Trial Updates: MAP Pharma, Cytokinetics, Hemispherx Post Big Gains
    on May 27, 2009 • ALTH, AMGN, BMY    
  • Clinical Trial Updates: Cancer Drugs in Focus as ASCO Approaches
    on May 18, 2009 • ALTH, AMGN, CRGN    
  • Opportunities in Healthcare: Highly Defensive Stocks
    on Apr 14, 2009 • ABT, ABV, AMGN    
  • Biotech Going Generic Like Big Pharma?
    on Mar 02, 2009 • AMGN, BIIB, CELG    
  • New Index of Highly Defensive Market Cap Leaders
    on Feb 26, 2009 • ABT, ABX, AMGN    
  • A 130/30 Generic Pharma Trading Strategy
    on Feb 24, 2009 • AMGN, AZN, BMY    
  • New Index of Health Product Innovators
    on Jan 05, 2009 • AMGN, CEPH, CVTX    
  • 4 Drug Stocks Trading Above Moving Averages
    on Dec 31, 2008 • AMGN, APPY, BDSI    
  • Five Highly Rated Healthcare Cost Containment Stocks
    on Dec 30, 2008 • AMGN, CVS, ESRX    
  • FDA Calendar Update: High Hopes for Amgen's Bone Drug
    on Dec 21, 2008 • ALO, AMAG, AMGN    
  • More Focused Defensive Index
    on Dec 03, 2008 • ABT, AMGN, DEF    
  • Three-Month, Updated FDA Decision Calendar
    on Dec 01, 2008 • AMGN, GENZ, JNJ    
  • Healthcare Stock Opportunities In a Down Market
    on Nov 22, 2008 • AMGN, APPY, CYPB    
  • 73 Decision Dates on Updated FDA Calendar
    on Nov 22, 2008 • AMGN, GSK, ISTA    
  • Who Will Take GM's Place in the Dow?
    on Nov 11, 2008 • AAPL, ABT, AMGN    
  • Backlog of Decisions Is Building at the FDA
    on Nov 08, 2008 • ALO, AMGN, CYPB    
  • 60 Defensive Growth Stocks
    on Oct 26, 2008 • ABTL, AMGN, CELG    
  • Amgen Exceeds Expectations, Again
    on Oct 22, 2008 • AMGN    
  • Earnings Encore for Amgen?
    on Oct 22, 2008 • AMGN    
  • Highly Defensive PerformIdex: 35 Stocks to Outpace the Markets
    on Aug 11, 2008 • ABX, AFL, AMGN    
  • I Still Like Amgen - Despite the Recent Run-up
    on Jul 29, 2008 • AMGN    
More on AMGN by Mike Havrilla
Articles by Ticker
AA, AAI, AAPL, AAWW, ABBC, ABFS, ABII, ABIO, ABMD, ABT, ABTL, ABV, ABX, ACAD, ACCP.OB, ACEL, ACHN, ACL, ACLI, ACOR, ACTC, ACTC.PK, ACUR, ACUS, ADAM, ADLR, ADLS, ADLS.OB, AET, AEZS, AFFX, AFFY, AFL, AGEN, AGN, AHBIF.PK, AIQ, AIRM, AIS, AKRX, ALEX, ALGT, ALK, ALKS, ALNPY.PK, ALNY, ALO, ALPMF.PK, ALTH, ALV,

Latest Comments on Mike Havrilla's Articles

  1. robin446 on Echo Therapeutics: Positive Developments for a Needle-Free Diabetes Monitoring System: Excellent article on diabetes. What a relief it would be to throw... more »
  2. fran grady on Diabetes Care: Global Investing Opportunities : yes why not mentioned? On Nov 22 08:13 AM nougatine1... more »
  3. saber Tooth on Diabetes Care: Global Investing Opportunities : The holy grail in the future of Diabetes and Obesity lies simply... more »
  4. rob134 on Diabetes Care: Global Investing Opportunities : Mike, If I may ask a question... I have been looking at several... more »
  5. nougatine1 on Diabetes Care: Global Investing Opportunities : And GNBT... more »
  6. saber Tooth on Echo Therapeutics: Positive Developments for a Needle-Free Diabetes Monitoring System: Huge potential market and many companys both private and public... more »
  7. Evelyn Guzman on Echo Therapeutics: Positive Developments for a Needle-Free Diabetes Monitoring System: I hope everything goes well with the development of this product... more »
  8. The Watchful Eye on BioMed News Bytes: Cytori, Questcor: QCOR estimates that as many as 2,000 children annually experience... more »
  9. jimmy Turano on BioMed News Bytes: Cytori, Poniard, Alkermes, Spherix, CRXX, HGSI: MIKE HAVRILLA-Let me be the first to wish you a Happy Thanksgiving... more »
  10. unblock school on Novartis: An Ex-U.S. Proxy for Global Healthcare: Thanks for great post Mike, Delta more »
  11. drgmoney on Access Pharma Looking for Smooth U.S. MuGard Launch in 2010: Do you know if the post marketing Data on Mugard in Europe will be... more »
  12. jay brebner on EXACT Sciences: Buy and Hold for Long-Term Upside: Thanks Charlie - I didn't know the stats off the top of my head... more »
  13. Super Stock Timer on BioMed News Bytes: Cytori, Questcor: 11-7-09 - BUY DNDN ON THE FIRST CLOSE ABOVE 29.00 - WALTER - SUPER... more »
  14. Charlie L on EXACT Sciences: Buy and Hold for Long-Term Upside: Agree that $300 every 3 years is a bargain compared to a $2,000... more »
  15. jay brebner on EXACT Sciences: Buy and Hold for Long-Term Upside: $300 per test is an absolute bargain to detect CRC early. the... more »